Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Linio Biotech Oy
With
Hospital Nova, Central Finland
Cell-free preparate of human adipose tissue is intended to be used in the human body for its original purpose to supplement and replace local extracellular matrix deficiencies in soft tissue, including skin. The tissue product provides a temporary conductive environment into the injured area. This facilitates the ability of local cells to re-populate the damaged soft tissue and skin area, thereby enabling the deposition of extracellular matrix and repair of the tissue.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Wound of at least 10 cm3 with an indication of skin graft surgery (two skin grafts harvested and used)
Adult (age 18 years or more)
Able and willing to give informed consent
Reasonably accessible to the study clinic and compliant to wound treatment
You may not be if
Known allergy to any of the preparation used in the study (Tience)
Systemic cancer (does not include carcinoma in situ of the cervix or local skin cancers such as basiloma)
Pregnancy or nursing
Those who withhold consent
Active infection on the receptor site, donor site or sepsis
Any other serious disease likely to compromise the outcome of the trial, such as critical renal disease (creatinine greater than 300 mmol/l)
Those living at such a distance from the clinic as would make frequent assessment visits inappropriately expensive and/or impractical.
Those with conditions, which tend to limit a patient´s ability or willingness to restrict activities or comply with the instructions during the treatment and follow-up period.